Skip to main content

Greenberg Traurig Patent Attorney, Dr. Fang Xie, Recognized in IAM Strategy 300 - The World’s Leading IP Strategists 2016

BOSTON — June 20, 2016 — Dr. Fang Xie, a registered patent attorney in Greenberg Traurig, LLP’s Boston office, was recognized as one of the world’s top IP value creators in the 2016 edition of the Intellectual Asset Management’s (IAM) Strategy 300 – The World’s Leading IP Strategists 2016. According to the publication, the guide identifies the individuals who are leading the way in the development and implementation of strategies that maximize the value of IP portfolios.

Fang Xie, Ph.D. is of counsel in the firm’s Intellectual Property Practice, focusing on developing, evaluating, and enforcing intellectual property rights. She has broad experience in worldwide patent and trademark portfolio development, intellectual property due diligence, licensing and technology transfer, patentability and product clearance studies, patent infringement and validity analyses, freedom to operate evaluations, as well as intellectual property litigation and pre-litigation counseling. Dr. Xie’s primary technical areas include biotechnology, synthetic biology, and pharmaceuticals, with a focus on nucleic acid synthesis, protein and organism engineering, antibody and biologics/biosimilars, stem cell technology, regenerative medicine, biomarkers, genetic diagnostics, small molecule drugs, analytical chemistry, and cosmetics. She regularly works with clients in the life sciences sector, including biotechnology, pharmaceutical, and chemistry companies, as well as venture capital and institutional investors. Dr. Xie also frequently works with early-stage bio-pharmaceutical companies to enhance their IP position and develop licensing and partnership strategies.